Cargando…
[(124)I]IBETA: A New Aβ Plaque Positron Emission Tomography Imaging Agent for Alzheimer’s Disease
Several fluorine-18-labeled PET β-amyloid (Aβ) plaque radiotracers for Alzheimer’s disease (AD) are in clinical use. However, no radioiodinated imaging agent for Aβ plaques has been successfully moved forward for either single-photon emission computed tomography (SPECT) or positron emission tomograp...
Autores principales: | Nguyen, Grace A.H., Liang, Christopher, Mukherjee, Jogeshwar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319930/ https://www.ncbi.nlm.nih.gov/pubmed/35889425 http://dx.doi.org/10.3390/molecules27144552 |
Ejemplares similares
-
Measurement of Aβ Amyloid Plaques and Tau Protein in Postmortem Human Alzheimer’s Disease Brain by Autoradiography Using [(18)F]Flotaza, [(125)I]IBETA, [(124/125)I]IPPI and Immunohistochemistry Analysis Using QuPath
por: Mondal, Rommani, et al.
Publicado: (2023) -
Development of [(124/125)I]IAZA as a New Proteinopathy Imaging Agent for Alzheimer’s Disease
por: Reddy, Thrisha T., et al.
Publicado: (2023) -
Coronary plaque instability assessed by positron emission tomography and optical coherence tomography
por: Galiuto, L., et al.
Publicado: (2021) -
F-18 Fluoride Positron Emission Tomography-Computed Tomography for Detecting Atherosclerotic Plaques
por: Kang, Won Jun
Publicado: (2015) -
Alzheimer’s Dementia: The Emerging Role of Positron Emission
Tomography
por: Tripathi, Shailendra Mohan, et al.
Publicado: (2021)